- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
|
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-256620, 333-267781, and 333-274167) and Form S-8 (No. 333-35151, 333-118546, 333-127574, 333-137954, 333-148660, 333-162610, 333-167515, 333-176365, 333-176366, 333-198853, 333-206165, 333-214503, 333-219830, 333-233023, 333-259518, 333-267352 and 333-273059) of Heron Therapeutics, Inc. our report dated March 12, 2024, relating to the consolidated financial statements as of and for the year ended December 31, 2023 and 2022, and the effectiveness of Heron Therapeutics, Inc.'s internal control over financial reporting as of December 31, 2023, included in this Annual Report on Form 10-K for the year ended December 31, 2023.
/s/ WithumSmith+Brown, PC
San Francisco, California
March 12, 2024